Table 2.
VA (logMAR) | CR | CR ≥1.5 | MD | ||||
Mean (SD) | Mean (SD) | N | Mean (SD) | ||||
95% CI | 95% CI | Fraction | 95% CI | ||||
Better eye | |||||||
Control subjects | N=44 | −0.14 (0.07) | N=44 | 1.20 (0.26) | 4 | N=43 | −0.80 (1.03) |
−0.16 to −0.12 | 1.13 to 1.28 | 0.09 | −1.12 to −0.48 | ||||
Prematures | N=59 | −0.08 (0.11) | N=59 | 1.26 (0.30) | 16 | N=56 | −1.09 (1.13) |
−0.11 to −0.05 | 1.18 to 1.34 | 0.27 | −1.39 to −0.79 | ||||
No ROP | N=36 | −0.10 (0.09) | N=36 | 1.27 (0.25) | 9 | N=35 | −0.93 (0.92) |
−0.13 to −0.07 | 1.18 to 1.35 | 0.25 | −1.25 to −0.62 | ||||
Untreated ROP | N=10 | −0.08 (0.10) | N=10 | 1.38 (0.30) | 4 | N=9 | −1.10 (1.61) |
−0.15 to −0.01 | 1.16 to 1.59 | 0.40 | −2.33 to 0.14 | ||||
Treated ROP | N=13 | −0.02 (0.14) | N=13 | 1.16 (0.40) | 3 | N=12 | −1.54 (1.26) |
−0.11 to 0.06 | 0.91 to 1.40 | 0.23 | −2.34 to −0.73 | ||||
Worse eye | |||||||
Control subjects | N=44 | −0.09 (0.08) | N=44 | 1.32 (0.27) | 14 | N=43 | −0.92 (1.16) |
−0.12 to −0.07 | 1.23 to 1.40 | 0.32 | −1.28 to −0.57 | ||||
Prematures | N=59 | 0.03 (0.27) | N=57 | 1.30 (0.30) | 16 | N=57 | −1.32 (1.19) |
−0.04 to 0.10 | 1.22 to 1.38 | 0.28 | −1.63 to −1.00 | ||||
No ROP | N=34 | 0.01 (0.30) | N=33 | 1.33 (0.31) | 8 | N=33 | −1.34 (1.15) |
−0.10 to 0.11 | 1.22 to 1.44 | 0.24 | −1.75 to −0.94 | ||||
Untreated ROP | N=12 | 0.01 (0.08) | N=12 | 1.28 (0.27) | 4 | N=12 | −1.07 (1.43) |
−0.04 to 0.06 | 1.11 to 1.45 | 0.33 | −1.98 to −0.17 | ||||
Treated ROP | N=13 | 0.09 (0.29) | N=12 | 1.25 (0.30) | 4 | N=12 | −1.49 (1.12) |
−0.09 to 0.26 | 1.06 to 1.44 | 0.33 | −2.20 to −0.78 |
CR, crowding ratio; N, number; ROP, retinopathy of prematurity; VA, visual acuity.